SomnoMed Limited (SOM.AX)
AUD 0.43
(-18.87%)
AUD 0.43
(-18.87%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 | 709.07 Thousand AUD | -95.66% |
| 2023 | 16.35 Million AUD | 712.34% |
| 2022 | 2.01 Million AUD | -14.26% |
| 2021 | 2.34 Million AUD | -6.39% |
| 2020 | 2.5 Million AUD | 598.6% |
| 2019 | 359.08 Thousand AUD | -65.37% |
| 2018 | 1.03 Million AUD | 1847.12% |
| 2017 | 53.25 Thousand AUD | 0.0% |
| 2016 | - AUD | 0.0% |
| 2015 | - AUD | 0.0% |
| 2014 | - AUD | 0.0% |
| 2013 | - AUD | 0.0% |
| 2012 | - AUD | 0.0% |
| 2011 | - AUD | -100.0% |
| 2010 | 1715.00 AUD | 0.0% |
| 2009 | - AUD | 0.0% |
| 2008 | - AUD | 0.0% |
| 2007 | - AUD | -100.0% |
| 2006 | 93.95 Thousand AUD | -63.13% |
| 2005 | 254.83 Thousand AUD | 0.0% |
| 2004 | - AUD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q4 | 709.07 Thousand AUD | 0.0% |
| 2024 FY | 709.07 Thousand AUD | -95.66% |
| 2024 Q2 | 11.64 Million AUD | 0.0% |
| 2023 FY | 16.35 Million AUD | 712.34% |
| 2023 Q4 | 16.35 Million AUD | 0.0% |
| 2023 Q2 | 16.5 Million AUD | 0.0% |
| 2022 Q4 | 2.01 Million AUD | 0.0% |
| 2022 Q2 | 2.28 Million AUD | 0.0% |
| 2022 FY | 2.01 Million AUD | -14.26% |
| 2021 FY | 2.34 Million AUD | -6.39% |
| 2021 Q2 | 2.27 Million AUD | 0.0% |
| 2021 Q4 | 2.34 Million AUD | 0.0% |
| 2020 Q2 | 5.1 Million AUD | 0.0% |
| 2020 Q4 | 2.5 Million AUD | 0.0% |
| 2020 FY | 2.5 Million AUD | 598.6% |
| 2019 Q4 | 359.08 Thousand AUD | 0.0% |
| 2019 Q2 | 1.06 Million AUD | 0.0% |
| 2019 FY | 359.08 Thousand AUD | -65.37% |
| 2018 Q2 | 675.53 Thousand AUD | 0.0% |
| 2018 FY | 1.03 Million AUD | 1847.12% |
| 2018 Q4 | 1.03 Million AUD | 0.0% |
| 2017 Q4 | 53.25 Thousand AUD | 0.0% |
| 2017 Q2 | - AUD | 0.0% |
| 2017 FY | 53.25 Thousand AUD | 0.0% |
| 2016 Q4 | - AUD | 0.0% |
| 2016 FY | - AUD | 0.0% |
| 2016 Q2 | - AUD | 0.0% |
| 2015 FY | - AUD | 0.0% |
| 2015 Q2 | - AUD | 0.0% |
| 2015 Q4 | - AUD | 0.0% |
| 2014 Q2 | - AUD | 0.0% |
| 2014 Q4 | - AUD | 0.0% |
| 2014 FY | - AUD | 0.0% |
| 2013 FY | - AUD | 0.0% |
| 2013 Q2 | - AUD | 0.0% |
| 2013 Q4 | - AUD | 0.0% |
| 2012 Q4 | - AUD | 0.0% |
| 2012 FY | - AUD | 0.0% |
| 2011 Q4 | - AUD | 0.0% |
| 2011 FY | - AUD | -100.0% |
| 2010 FY | 1715.00 AUD | 0.0% |
| 2010 Q4 | - AUD | 0.0% |
| 2009 FY | - AUD | 0.0% |
| 2009 Q4 | - AUD | 0.0% |
| 2008 FY | - AUD | 0.0% |
| 2008 Q4 | - AUD | 0.0% |
| 2007 Q4 | - AUD | 0.0% |
| 2007 FY | - AUD | -100.0% |
| 2006 FY | 93.95 Thousand AUD | -63.13% |
| 2006 Q4 | 93.95 Thousand AUD | 0.0% |
| 2005 FY | 254.83 Thousand AUD | 0.0% |
| 2005 Q4 | 254.83 Thousand AUD | 0.0% |
| 2004 FY | - AUD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| 4DMedical Limited | 4.17 Million AUD | 83.02% |
| Adherium Limited | - AUD | -Infinity% |
| Aroa Biosurgery Limited | 5.89 Million AUD | 87.981% |
| Atomo Diagnostics Limited | - AUD | -Infinity% |
| Anteris Technologies Ltd | 1.52 Million AUD | 53.632% |
| Control Bionics Limited | 336.16 Thousand AUD | -110.93% |
| CardieX Limited | - AUD | -Infinity% |
| Compumedics Limited | - AUD | -Infinity% |
| Cochlear Limited | 202.1 Million AUD | 99.649% |
| CleanSpace Holdings Limited | 2.76 Million AUD | 74.369% |
| Cyclopharm Limited | 4.01 Million AUD | 82.33% |
| EMVision Medical Devices Ltd | 1.76 Million AUD | 59.859% |
| Nova Eye Medical Limited | - AUD | -Infinity% |
| HeraMED Limited | - AUD | -Infinity% |
| Imricor Medical Systems, Inc. | 12.43 Million AUD | 94.299% |
| ImpediMed Limited | 810 Thousand AUD | 12.46% |
| InhaleRx Limited | - AUD | -Infinity% |
| LBT Innovations Limited | 1.74 Million AUD | 59.319% |
| Micro-X Limited | 65 Thousand AUD | -990.883% |
| Neurotech International Limited | - AUD | -Infinity% |
| OncoSil Medical Limited | - AUD | -Infinity% |
| PolyNovo Limited | 742 Thousand AUD | 4.437% |
| Respiri Limited | - AUD | -Infinity% |
| Universal Biosensors, Inc. | 3.22 Million AUD | 78.018% |
| Uscom Limited | - AUD | -Infinity% |
| Visioneering Technologies, Inc. | - AUD | -Infinity% |